Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TLR5 Stable Cell Line

    [CAT#: S01YF-1023-PY211]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Immune Checkpoint Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Immune Checkpoint
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;4T1
    Target Classification
    Immune Checkpoint Cell Lines
    Target Research Area
    Infectious Research
    Related Diseases
    Legionnaire Disease; Melioidosis
    Gene ID
    Human:7100
    UniProt ID
    Human:O60602

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Toll-like receptor 5 (TLR5) is a member of the TLR family, which plays a critical role in innate immunity by recognizing specific molecular patterns associated with pathogens. TLR5 specifically recognizes bacterial flagellin, a component of the flagella in motile bacteria. Activation of TLR5 can lead to the induction of pro-inflammatory cytokines and the development of adaptive immune responses. Recent studies have highlighted the role of TLR5 in regulating gut microbiota and its potential therapeutic implications in conditions like inflammatory bowel disease and bacterial infections. Moreover, TLR5 signaling has been linked to bacterial translocation after traumatic hemorrhagic shock, suggesting potential therapeutic interventions targeting this pathway.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human TLR5 Stable Cell Line (S01YF-1023-PY211). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Cameron Williams (Verified Customer)

    How does TLR5 function in the immune response to bacterial infections? Jul 31 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TLR5 recognizes bacterial flagellin, activating immune responses that can be crucial in defending against infections and potentially useful in developing new therapeutic strategies. Jul 31 2022

    chat Alex Garcia (Verified Customer)

    Can TLR5 be targeted for treating inflammatory diseases? Nov 11 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TLR5 plays a role in modulating inflammation, such as in conditions like Crohn's disease, and targeting its signaling pathway could offer new approaches for treating these diseases. Nov 11 2022

    Published Data

    Fig.1 TLR5 downregulation promoted EMT in 4T1 cells.

    A western blot analysis was conducted in triplicate to detect the protein expression levels of TLR5, E-cadherin, N-cadherin, vimentin, fibronectin, TRAF6, SOX2 and Twist1 in TLR5 positive and TLR5 negative 4T1 cells. The results demonstrated statistically significant differences (p < 0.05) in the expression of all proteins examined between the two cell types, with TLR5 positive 4T1 cells exhibiting higher levels of mesenchymal markers and lower levels of epithelial markers. Further investigation into the phenotypic and functional variances induced by TLR5 signaling in this murine breast cancer model is warranted.

    Ref: Shi, Dai, et al. "TLR5: A prognostic and monitoring indicator for triple-negative breast cancer." Cell Death & Disease 10.12 (2019): 954.

    Pubmed: 31852883

    DOI: 10.1038/s41419-019-2187-8

    Research Highlights

    Bhardwaj, Ananya. et al. "Role of toll-like receptor in the pathogenesis of oral cancer." Cell biochemistry and biophysics, 2023.
    The significance of toll-like receptors as vital components of innate immunity is well recognized. These receptors are classified as pattern recognition receptors as they have the ability to identify specific molecules, known as pathogen-associated molecular patterns, on pathogens. Upon recognition, they release chemical signals that promote an inflammatory response. Toll-like receptors play a crucial role in eliminating infected cells and preventing the spread of infection, making them potential targets for cancer research. Oral cancer is a prevalent issue in many countries, and it has been found that toll-like receptors are involved in its development. Certain variations in toll-like receptor genes have been linked to an increased susceptibility to oral cancer. By identifying toll-like receptors and their associated genotypes, they can potentially serve as biomarkers for this disease. Recent studies have also shown that specific toll-like receptors, such as TLR7 and TLR5, inhibit the progression of oral cancer, while others, such as TLR4 and TLR2, are linked to its advancement. Therefore, toll-like receptors have the potential to be targeted for the development of effective therapeutic strategies for oral cancer.
    Bhardwaj, Ananya. et al. "Role of toll-like receptor in the pathogenesis of oral cancer." Cell biochemistry and biophysics, 2023.
    Pubmed: 37853249   DOI: 10.1007/s12013-023-01191-8

    Gautam, Priyanka. et al. "Genome-wide expression profiling reveals novel biomarkers in epithelial ovarian cancer." Pathology, research and practice, 2023.
    Epithelial ovarian cancer (EOC) is a highly aggressive and common form of cancer affecting women globally. Understanding the pathophysiology of EOC is crucial in order to identify new biomarkers for early detection, management, and prognostication. In this study, the researchers aimed to analyze RNA-seq data to investigate the transcriptomic landscape and biomarkers. This was followed by further analysis using Protein Protein network, which identified the top 10 Differentially Expressed Genes (DEGs). The team also conducted KEGG pathway enrichment analysis, revealing the significant enrichment of DEGs in basal cell carcinoma, cell cycle, and FoxO signalling pathway. To validate their findings, the researchers used QRT-PCR and TCGA database. Correlation studies between gene expression and clinical characteristics were also performed, as well as survival analysis. This study identified 8 DEGs (CDKN1A, BCL6, CDC45, WNT2, TLR5, AQP5) and 2 novel DEGs (CSN1S1 and NKILA) that showed significant correlations with EOC characteristics. These DEGs could potentially be used as biomarkers and treatment targets, and further research on their functional outcomes is warranted.
    Gautam, Priyanka. et al. "Genome-wide expression profiling reveals novel biomarkers in epithelial ovarian cancer." Pathology, research and practice, 2023.
    Pubmed: 37844484   DOI: 10.1016/j.prp.2023.154840

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare